Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity, avidity and specificity

Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity, avidity and specificity

US Patent 11325970 · Granted May 10, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fc containing polypeptides with altered glycosylation and reduced effector funct2025
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidi2025
scFv-Fc dimers that bind transforming growth factor-β1 with high affinity, avidi2025
Anti-alpha beta TCR binding polypeptides with reduced fragmentation2025
Tumor-specific cleavable linkers2025
Anti-CHIKV antibodies and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025
Modified-IgG antibodies that bind transforming growth factor-β1 with high affini2024
Modified-IgG antibodies that bind transforming growth factor-β1 with high affini2024
Site-specific antibody-drug conjugation through glycoengineering2024
Bone-targeting antibodies2024
Anti-TGF-beta antibodies and their use2024